MedPath

湖北中佳药业有限公司

Ownership
-
Established
2001-03-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

88

NMPA:88

Drug Approvals

Clindamycin Phosphate Injection

Product Name
克林霉素磷酸酯注射液
Approval Number
国药准字H20066702
Approval Date
Jun 16, 2021
NMPA

Troxerutin and Sodium Chloride Injection

Product Name
曲克芦丁氯化钠注射液
Approval Number
国药准字H20064501
Approval Date
Jun 15, 2021
NMPA

Lincomycin Hydrochloride Injection

Product Name
盐酸林可霉素注射液
Approval Number
国药准字H42020643
Approval Date
Sep 18, 2020
NMPA

Compound Sodium Chloride Injection

Product Name
复方氯化钠注射液
Approval Number
国药准字H42020824
Approval Date
Sep 18, 2020
NMPA

Lomefloxacin Hydrochloride and Sodium Chloride Injection

Product Name
盐酸洛美沙星氯化钠注射液
Approval Number
国药准字H10980061
Approval Date
Sep 18, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H42020842
Approval Date
Sep 18, 2020
NMPA

Xylitol Injection

Product Name
木糖醇注射液
Approval Number
国药准字H20044795
Approval Date
Sep 18, 2020
NMPA

Amikacin Sulfate Injection

Product Name
硫酸阿米卡星注射液
Approval Number
国药准字H42020626
Approval Date
Sep 18, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H42020841
Approval Date
Sep 18, 2020
NMPA

Vitamin B6 Injection

Product Name
维生素B6注射液
Approval Number
国药准字H42020641
Approval Date
Sep 18, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.